Insulin resistance, common co-existing with NAFLD, is contributed by inflammatory factors binding to IRS for ubiquitin-mediated degradation via the activation of Suppressors of Cytokine Signalling 3 (SOCS3). The gene discussed is SOCS3; the disease is metabolic dysfunction-associated steatotic liver disease.